Journal
DRUG METABOLISM AND DISPOSITION
Volume 34, Issue 9, Pages 1600-1605Publisher
AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/dmd.106.010793
Keywords
-
Categories
Ask authors/readers for more resources
Apparent intrinsic clearance (CLint, app) of 7-ethoxycoumarin, phenacetin, propranolol, and midazolam was measured using rat and human liver microsomes and freshly isolated and cryopreserved hepatocytes to determine factors responsible for differences in rates of metabolism in these systems. The cryopreserved and freshly isolated hepatocytes generally provided similar results, although there was greater variability using the latter system. The CLint, app values in hepatocytes are observed to be lower than that in microsomes, and this difference becomes greater for compounds with high CLint, app. This could partly be attributed to the differences in the free fraction (f(u)). The f(u) in hepatocyte incubations (f(u,hep- inc)) was influenced not only by the free fraction of compounds in the incubation buffer ( fu, buffer) but also by the rate constants of uptake (k(up)) and metabolism (k(met)). This report provides a new derivation for fu, hep- inc, which can be expressed as f(u,hep-inc) = [k(up)/(k(met) + k(up))]/[ 1 + ( C-hep/ C-buffer) x ( V-hep/ V-buffer)], where the C-hep, C-buffer, V-hep, and V-buffer represent the concentrations of a compound in hepatocytes and buffer and volumes of hepatocytes and buffer, respectively. For midazolam, the f(u,hep- inc) was calculated, and the maximum metabolism rate in hepatocytes was shown to be limited by the uptake rate.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available